The RCPA advocates for a collaborative approach for the successful introduction of pharmacogenetics in healthcare in Australia
22 February, 2019

The Royal College of Pathologists of Australasia (RCPA) has released a new position statement on the significance of genetic testing to predict a patient’s response to drugs, also known as pharmacogenetics. The RCPA is advocating for a collaborative approach with medical colleges and the wider medical profession, the Government, educators, and researchers, with the aim of creating national guidelines that will facilitate the safe and appropriate introduction of pharmacogenetics in Australia. By using pharmacogenetic testing, a clinician can align a prescription with the patient’s potential for a beneficial or adverse response to a drug.

Go Back

Page last updated:

Copyright © 2019 RCPA. All rights reserved.

27-Feb-2019
Top